首頁 › 膀胱癌 › 賓夕法尼亞州 › Pittsburgh
Pittsburgh, PA 的 膀胱癌 臨床試驗
7 項針對 膀胱癌 的研究正在 Pittsburgh（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
招募中2 期
- UPMC-Magee Womens Hospital, Pittsburgh
- UPMC-Saint Margaret, Pittsburgh
- UPMC Hillman Cancer Center, Pittsburgh
- 還有 7 項
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
招募中2 期
- UPMC Hillman Cancer Center, Pittsburgh
- UPMC-Passavant Hospital, Pittsburgh
- UPMC-Saint Clair Hospital Cancer Center, Pittsburgh
- 還有 2 項
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
招募中3 期
- AHN Allegheny General Hospital, Pittsburgh
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
招募中2 期
- University of Pittsburgh Medical Center, Pittsburgh
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
招募中1 期
- Allegheny General Hospital, Pittsburgh
- University of Pittsburgh Medical Center, Pittsburgh
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
招募中觀察性研究
- Allegheny Health Network, Pittsburgh
Virtual Histology of the Bladder Wall for Bladder Cancer Staging
招募中早期第 1 期
- UPMC Hillman Cancer Center - Dept of Urology, Pittsburgh
其他城市的 膀胱癌 試驗
- New York City, NY35 項研究
- Nashville, TN31 項研究
- Houston, TX31 項研究
- Dallas, TX27 項研究
- Washington, DC26 項研究
- Boston, MA26 項研究
- Baltimore, MD24 項研究
- Los Angeles, CA24 項研究
- St. Louis, MO22 項研究
- Seattle, WA21 項研究
- Chicago, IL21 項研究
- Philadelphia, PA21 項研究
Pittsburgh 的其他研究
- 非小細胞肺癌48 項研究
- 癌症（所有類型）41 項研究
- 乳癌39 項研究
- 大腸直腸癌32 項研究
- 轉移性癌症31 項研究
- 黑色素瘤31 項研究
- 卵巢癌30 項研究
- 子宮內膜癌23 項研究
- 前列腺癌23 項研究
- 肺癌23 項研究
- 頭頸部鱗狀細胞癌22 項研究
- 中風22 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。